Literature DB >> 7648648

Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

S Yusuf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648648     DOI: 10.1161/01.cir.92.5.1079

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  Antihypertensive therapy in the prevention of stroke: what, when and for whom?

Authors:  M D Fotherby; B Panayiotou
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

2.  Controversies concerning calcium antagonists.

Authors:  P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

3.  Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction.

Authors:  S R Majumdar; T S Inui; J H Gurwitz; M W Gillman; T J McLaughlin; S B Soumerai
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

Review 4.  Clinical roles of calcium channel blockers in ischemic heart diseases.

Authors:  Daisuke Sueta; Noriaki Tabata; Seiji Hokimoto
Journal:  Hypertens Res       Date:  2017-01-26       Impact factor: 3.872

Review 5.  Calcium antagonists during and after myocardial infarction.

Authors:  P Sleight
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

Review 6.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

7.  Targeting converging therapeutic pathways to overcome hypertension.

Authors:  Kwang Kon Koh; Michael J Quon
Journal:  Int J Cardiol       Date:  2009-01-10       Impact factor: 4.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.